Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma Cells
Open Access
- 1 April 2002
- journal article
- Published by Elsevier
- Vol. 277 (17) , 15035-15043
- https://doi.org/10.1074/jbc.m112028200
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Identification of genes differentially expressed in association with acquired cisplatin resistanceBritish Journal of Cancer, 2000
- Cisplatin resistance and oncogenes - a reviewAnti-Cancer Drugs, 2000
- Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transferOncogene, 1998
- Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cellsBritish Journal of Cancer, 1997
- Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumorsCancer Chemotherapy and Pharmacology, 1995
- Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexesBritish Journal of Cancer, 1992
- Modulation of cis-diamminedichloroplatinum(II) resistance: a reviewBritish Journal of Cancer, 1992
- Enhanced DNA repair and resistance to cisplatin in human ovarian cancerBiochemical Pharmacology, 1988
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- CisplatinAnnals of Internal Medicine, 1984